A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing

Summary

This study will evaluate the safety and effectiveness of fluoxetine flexible dosing in the treatment of MDD in adult Japanese participants. Participants who complete the short-term treatment phase of Study B1Y-JE-HCLV (NCT#: NCT01808612) will be allowed to enroll in this study, and receive fluoxetine treatment for an additional 52 weeks.

Timeline

Start

2013-05

Primary completion

2015-03

Completion

2015-03

Drugs

Indications